![]() |
Volumn 80, Issue 5, 2005, Pages 704-706
|
Steroid-free living-donor liver transplantation in adults
|
Author keywords
Liver transplantation; Living donor; Steroid free
|
Indexed keywords
BASILIXIMAB;
DACLIZUMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ADULT;
AGED;
ALLOGRAFT;
ARTICLE;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
FEMALE;
GRAFT SURVIVAL;
HIGH RISK PATIENT;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
LIVER TRANSPLANTATION;
LIVING DONOR;
MALE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RECIPIENT;
RISK BENEFIT ANALYSIS;
ACUTE DISEASE;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
DISEASE-FREE SURVIVAL;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATITIS C, CHRONIC;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
PROSPECTIVE STUDIES;
RECOMBINANT FUSION PROTEINS;
STEROIDS;
TREATMENT OUTCOME;
|
EID: 25444493863
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/01.tp.0000172187.28376.3b Document Type: Article |
Times cited : (21)
|
References (5)
|